DJIA 17,110.15 135.84 0.80%
NASDAQ 4,538.47 -10.76 -0.24%
S&P 500 1,984.17 1.87 0.09%
market minute promo

PHARMACYCLICS, INC. (NASDAQ: PCYC)

134.77 2.69 (2.04%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PCYC $134.77 2.04%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $132.09
Previous Close $132.08
Daily Range $130.93 - $134.90
52-Week Range $82.51 - $154.89
Market Cap $10.1B
P/E Ratio 112.89
Dividend (Yield) $0.00 (0.0%)
Volume 171,990
Average Daily Volume 791,583
Current FY EPS $0.28

Sector

Healthcare

Industry

Drugs

PHARMACYCLICS, INC. (PCYC) Description

A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases. Website: http://www.pharmacyclics.com/

News & Commentary Rss Feed

Johnson & Johnson and Bristol-Myers Squibb’s New Collaboration Just the Tip of the Iceberg

Bristol-Myers Squibb's Opdivo and Merck's Keytruda are sought after drugs for combination cancer treatments.

The Time Is Now For Northwest Biotherapeutics

Wainwright Sees TG Therapeutics As Take-Out Target

Pharmacyclics Up on Label Expansion Efforts for Imbruvica - Analyst Blog

Sector Update: Health Stocks Higher Pre-Bell

Sector Update: Health Care

Pharmacyclics, Roche Ink Deal for Cancer Combo Therapy - Analyst Blog

Sector Update: Health Stocks Higher Pre-Bell

Sector Update: Health Care

Pharmacyclics Enters Into Agreement With Roche To Evaluate IMBRUVICA And GAZYVA In Lymphoma And Leuk

Pharmacyclics Enters Into Agreement With Roche To Evaluate IMBRUVICA And GAZYVA In Lymphoma And Leukemia

See More PCYC News...

PCYC's Top Competitors

PCYC $134.77 (2.04%)
Current stock: PCYC
AMGN $159.89 (0.64%)
Current stock: AMGN
GILD $113.93 (2.90%)
Current stock: GILD
BIIB $321.35 (2.00%)
Current stock: BIIB